1-5 of 5
Guido Tricot
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia

Mu Hao, Bart Barlogie, Guido Tricot, Lanting Liu, Lugui Qiu, John D. Shaughnessy, Jr, Fenghuang Zhan
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (1): 201–209.
https://doi.org/10.1158/1078-0432.CCR-18-1435
Published: 03 January 2019
View article titled, Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia
Open the PDF for Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia in another window
Includes: Supplementary data
Journal Articles

NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma

Junwei Huang, Yi Zhou, Gregory S. Thomas, Zhimin Gu, Ye Yang, Hongwei Xu, Guido Tricot, Fenghuang Zhan
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5532–5542.
https://doi.org/10.1158/1078-0432.CCR-15-0254
Published: 14 December 2015
View article titled, NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma
Open the PDF for NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma

Markus Hansson, Peter Gimsing, Ashraf Badros, Titti Martinsson Niskanen, Hareth Nahi, Fritz Offner, Morten Salomo, Elisabeth Sonesson, Morten Mau-Sorensen, Yvonne Stenberg, Annika Sundberg, Ingrid Teige, Jan Van Droogenbroeck, Stina Wichert, Maurizio Zangari, Björn Frendeus, Magnus Korsgren, Martine Poelman, Guido Tricot
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (12): 2730–2736.
https://doi.org/10.1158/1078-0432.CCR-14-3090
Published: 14 June 2015
View article titled, A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Open the PDF for A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling

Jeffrey Haessler, John D. Shaughnessy, Jr., Fenghuang Zhan, John Crowley, Joshua Epstein, Frits van Rhee, Elias Anaissie, Mauricio Pineda-Roman, Maurizio Zangari, Klaus Hollmig, Abid Mohiuddin, Yazan Alsayed, Antje Hoering, Guido Tricot, Bart Barlogie
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 7073–7079.
https://doi.org/10.1158/1078-0432.CCR-07-0527
Published: 03 December 2007
View article titled, Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling
Open the PDF for Benefit of Complete Response in Multiple Myeloma Limited to High-Risk Subgroup Identified by Gene Expression Profiling in another window
Includes: Supplementary data
Journal Articles

Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients

Naoko Takebe, Xiangfei Cheng, Suhlan Wu, Kenneth Bauer, Olga G. Goloubeva, Robert G. Fenton, Meyer Heyman, Aaron P. Rapoport, Ashraf Badros, John Shaughnessy, Douglas Ross, Barry Meisenberg, Guido Tricot
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (24): 8301–8308.
https://doi.org/10.1158/1078-0432.CCR-04-0747
Published: 28 December 2004
View article titled, Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients
Open the PDF for Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients in another window